menu close
eikontx.com

Eikon Therapeutics Stock

Company Profile:

Eikon Therapeutics is a biotechnology company focused on pioneering new methods of drug discovery through advanced imaging techniques. Eikon aims to revolutionize the understanding of protein dynamics and their implications for therapeutic development.

Sign up for SecondMarket™ to view the market and buy or sell Eikon Therapeutics Stock
Buy + Sell

Eikon Therapeutics Funding

Sign up to gain insights into Eikon Therapeutics funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
May 16, 2023 Series B 140.76M
Price
Valuation
Jan 03, 2022 Series B 17.76M
Price
Valuation
Dec 03, 2021 Series A 500.00M
Price
Valuation
May 04, 2021 Series A 102.54M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

Eikon Therapeutics Management Team

  • CFO

    W. Bradley Yale

  • CEO

    Sidharth Malik

  • CSO

    Dr. Catherine Feuillet

  • Co-Founder, COO, Director

    Jamison Glenn

  • Director

    Christopher Gabrieli

  • Chief Marketing Officer

    Elizabeth Egan

  • Co-founder, CEO, Director

    Tim Zheng

  • Director

    Robert R. Schmidt

  • Director

    Julie Anne Smith

  • Chief People Officer

    Shobana Kailash

  • COO

    Jeremy Delinsky

  • Chief Marketing Officer

    Josh Harbert

  • Co-Founder, CTO, Director

    Jonathan Perichon

  • Chief Revenue Officer

    Adrian Agostini

  • Director

    James Tannanbaum

  • Chief Scientific Officer

    Dan Anderson

  • Chief Financial Officer

    Alfred Bowie

  • Chief People Officer

    Barbara Howes

  • Co-founder

    Xavier Darzacq

  • Co-founder

    Robert Tjian

  • Chief Technical Officer

    Russ Berman

  • Director

    Kenneth Frazier

  • Co-Founder

    Joel Webber

  • Chief Business Officer

    Benjamin Thorner

  • Director

    Dror Berman

  • Chief Medical Officer

    Roy Baynes

  • Director

    Deborah Winshel

  • Co-founder

    Eric Betzig

  • Chief Information Officer

    Ashish Kheterpal

  • President, Director

    Leon Chen

  • Chief Customer Officer

    Inder Sidhu

  • CEO, Director

    Roger Perlmutter

  • Director

    Adam Goulburn

  • Director

    Josh Wolfe

  • Director

    Robin Washington

  • Director

    Jishnu Bhattacharjee

Eikon Therapeutics Major Investors

  • Column Group

  • UC Investments (UCOP)

  • Horizon Ventures

  • E15 VC

  • AME Cloud Ventures LLC

  • Hartford HealthCare Endowment

  • T. Rowe Price Associates, Inc.

  • T. Rowe Price Associates, Inc.

  • Lux Capital

  • StepStone Group LLC

  • Harel Insurance Investements & Financial Services Ltd.

  • Foresite Capital

  • Innovation Endeavors LLC

  • General Catalyst Partners LLC

  • Schroders PLC

  • Canada Pension Plan Investment Board (CPPIB)

  • Soros Fund Management, LLC

  • Soros Fund Management, LLC

  • Abu Dhabi Investment Authority (ADIA)

  • EcoR1 Capital

Learn More About Eikon Therapeutics Stock

Buy Eikon Therapeutics Stock
01
Eikon Therapeutics stock does not trade on public stock exchanges. Eikon Therapeutics stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in Eikon Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.
Sell Eikon Therapeutics Stock
02
Eikon Therapeutics Stock does not trade on public stock exchanges. In order to sell Eikon Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.
Eikon Therapeutics Stock Price
03
Eikon Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Eikon Therapeutics share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Eikon Therapeutics Stock Ticker Symbol
04
There is no ticker symbol for Eikon Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell Eikon Therapeutics Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Eikon Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in Eikon Therapeutics Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in Eikon Therapeutics stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Eikon Therapeutics Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
Eikon Therapeutics IPO
08
Eikon Therapeutics is a private company and has not had an IPO. There is currently no Eikon Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Eikon Therapeutics IPO.
Sign up for SecondMarket™ to view the market and buy or sell Eikon Therapeutics Stock
Buy + Sell

Other Companies

Aircall

A top choice for modern businesses, offering a cloud-based call center and phone system that integrates seamlessly with popular tools.

Monte Carlo

AI-powered platform providing a view of data health and reliability for businesses.

insitro

Drug discovery and development company.

Eat Just

Food technology company specializing in plant-based egg ingredients.

Brain

Software for autonomous systems.

Attentive Mobile

AI marketing platform that provides personalized mobile messaging.

Source: Nasdaq Private Market Tape D™